Hypervision Surgical (“Hypervision”) proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the HYPERSNAP® Surgical System — the first intraoperative platform to combine Hyperspectral Imaging (HSI) with AI-powered analytics for real-time surgical decision support.
Read moreWe are thrilled to welcome Dr Rick Mangat, a global leader in surgical imaging, as a Strategic Advisor to Hypervision Surgical.
Read moreHypervision Surgical has expanded its R&D team with the appointment of Maximilian Kiss as a Research Scientist.
Read moreHypervision Surgical has further grown its team, with Kate Groves joining as Business Operations Officer.
Read moreIn March 2025, Hypervision Surgical had the distinct honour of presenting its groundbreaking HYPERSNAP® Surgical System to Her Royal Highness The Princess Royal during her official visit to King’s College London.
Read moreHypervision Surgical has expanded its team with the appointment of Stuti Pant as Research Development Manager, strengthening the company’s focus on public investment and grant funding.
Read more
